Latest Regulatory Risks News

Newmont Corporation delivered a standout first quarter in 2026, reporting $3.3 billion net income and $3.1 billion free cash flow, while authorising an additional $6 billion share repurchase program after completing the previous one.

Qube Holdings Limited is set for a $9.3 billion cash takeover by a Macquarie-led consortium, with court approval granted to convene shareholder meetings in June. The scheme offers shareholders a 28% premium and is backed by an independent expert's fair and reasonable opinion.

Cambium Bio has secured FDA confirmation that a single pivotal Phase 3 trial plus confirmatory evidence will suffice for Biologics License Application submission for Elate Ocular, significantly reducing development expenses and accelerating the pathway to market.

Tartana Minerals has closed a $275,000 share placement to its directors at a significant premium, issuing 5.5 million shares and promising options exercisable at 5.5 cents. The company also flagged imminent settlement of a larger $1.7 million placement from earlier this year.

Peninsula Energy (ASX: PEN) has voluntarily suspended trading of its shares pending a Supreme Court decision on the validity of share sales made earlier this year. The court hearing, set for 22 April, will determine if required disclosures were properly made for sales between February and April 2026.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

Synlait Milk Limited confirms extended product release times and supply chain disruptions following The a2 Milk Company's update on its China infant formula business. The company maintains no FY26 guidance amid persistent industry risks.

Zinc of Ireland NL (ASX: ZMI) has entered a binding agreement to acquire Dutch metals technology company Meclex, integrating proprietary hydrometallurgical processes ARGO and VOLTA with its Kildare Zinc project. The company also announced a $5.5 million placement to support exploration and technology development alongside new board appointments.

AuMEGA Metals Limited has launched a prospectus for a dual-tranche capital raising totalling approximately C$23.7 million, subject to shareholder approval, aimed at advancing its exploration programs in Newfoundland and Labrador, Canada.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.

The Australian Treasurer has issued interim directions preventing Hong Kong Ying Tak Limited from transferring or voting over 361 million shares in Northern Minerals, amid suspected breaches of foreign investment disposal orders. Northern Minerals is cooperating with regulators while focusing on its rare earths project.